BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 21920365)

  • 1. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.
    Mukhopadhyay R; Mukherjee S; Mukherjee B; Naskar K; Mondal D; Decuypere S; Ostyn B; Prajapati VK; Sundar S; Dujardin JC; Roy S
    Int J Parasitol; 2011 Nov; 41(13-14):1311-21. PubMed ID: 21920365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.
    Samant M; Sahasrabuddhe AA; Singh N; Gupta SK; Sundar S; Dube A
    Parasitology; 2007 Aug; 134(Pt 9):1175-84. PubMed ID: 17362540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
    Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
    J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of natural antimony resistance in Leishmania donovani isolates.
    Mittal MK; Rai S; Ashutosh ; Ravinder ; Gupta S; Sundar S; Goyal N
    Am J Trop Med Hyg; 2007 Apr; 76(4):681-8. PubMed ID: 17426170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
    Pal S; Mandal A; Duttagupta S
    Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy.
    Carter KC; Hutchison S; Boitelle A; Murray HW; Sundar S; Mullen AB
    Parasitology; 2005 Dec; 131(Pt 6):747-57. PubMed ID: 16336728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance.
    Bhandari V; Kumar D; Verma S; Srividya G; Negi NS; Singh R; Salotra P
    Biochem Biophys Res Commun; 2013 Nov; 440(4):646-51. PubMed ID: 24103752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
    Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME
    Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani.
    Kothari H; Kumar P; Sundar S; Singh N
    Parasitol Int; 2007 Mar; 56(1):77-80. PubMed ID: 17169604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
    Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
    J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation.
    Haldar AK; Yadav V; Singhal E; Bisht KK; Singh A; Bhaumik S; Basu R; Sen P; Roy S
    PLoS Pathog; 2010 May; 6(5):e1000907. PubMed ID: 20502630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines.
    Ouakad M; Vanaerschot M; Rijal S; Sundar S; Speybroeck N; Kestens L; Boel L; De Doncker S; Maes I; Decuypere S; Dujardin JC
    Parasitology; 2011 Sep; 138(11):1392-9. PubMed ID: 21819638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani.
    Mukherjee A; Padmanabhan PK; Singh S; Roy G; Girard I; Chatterjee M; Ouellette M; Madhubala R
    J Antimicrob Chemother; 2007 Feb; 59(2):204-11. PubMed ID: 17213267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.
    Sinha R; Roychoudhury J; Palit P; Ali N
    Antimicrob Agents Chemother; 2015 Jan; 59(1):344-55. PubMed ID: 25367907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection.
    Mookerjee Basu J; Mookerjee A; Banerjee R; Saha M; Singh S; Naskar K; Tripathy G; Sinha PK; Pandey K; Sundar S; Bimal S; Das PK; Choudhuri SK; Roy S
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1080-93. PubMed ID: 18056276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of aquaglyceroporin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of Leishmania donovani.
    Maharjan M; Singh S; Chatterjee M; Madhubala R
    Am J Trop Med Hyg; 2008 Jul; 79(1):69-75. PubMed ID: 18606765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India.
    Singh N; Chatterjee M; Sundar S
    Parasit Vectors; 2014 Dec; 7():596. PubMed ID: 25515494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic adaptations of Leishmania donovani in relation to differentiation, drug resistance, and drug pressure.
    Berg M; Vanaerschot M; Jankevics A; Cuypers B; Maes I; Mukherjee S; Khanal B; Rijal S; Roy S; Opperdoes F; Breitling R; Dujardin JC
    Mol Microbiol; 2013 Oct; 90(2):428-42. PubMed ID: 24020363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani.
    Carter KC; Mullen AB; Sundar S; Kenney RT
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3555-9. PubMed ID: 11709339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.